European Archives - Page 168 of 1392 - European Medical Journal

Early Detection of Brain Diseases with Speech-Based AI Screening

AI speech analysis detects neurological disorders with over 90 percent accuracy, promising rapid non-invasive screening worldwide.

Obesity and Inactivity Raise Cancer Risk in Childhood Cancer Survivors

Childhood cancer survivors who are obese and less physically active face a significantly higher risk of developing subsequent cancers later in life, according to new research….

Avacopan Cuts Steroid Use in Vasculitis Remission

A Japanese study shows avacopan helps induce remission in MPA and GPA while reducing steroid doses and adverse events, even when serum C5a levels remain unchanged.

Skincare Boosts Psoriasis Outcomes, Study Finds

While medical treatments remain the cornerstone of care, skincare is increasingly being recognised as a valuable adjunct to therapy.

Study Backs Colorectal Cancer Screening Starting at 45 Years

A study of over 235,000 colonoscopies found that people aged 45–49 had similar polyp and carcinoma detection rates as those aged 50–54, supporting earlier colorectal cancer screening.

Digital Intervention Reduces Cardiovascular Risk in Uncontrolled Diabetes

Find out how app-based messaging supports diabetes management and reduces cardiovascular risks in adults with poor control. Keep reading.

AI Tool Accurately Diagnoses and Grades COPD from CT Scans

Understand how an AI model uses chest CT scans to diagnose COPD with 95% accuracy.

Metabolic Syndrome Increases Parkinson’s Disease Risk

A large cohort study using data from the UK Biobank has found that metabolic syndrome is associated with an increased risk of developing Parkinson’s disease, particularly in individuals with a high genetic predisposition.

AI Model Shows Breakthrough in Non-Invasive Prostate Cancer Diagnosis

A groundbreaking AI model, trained on over 1.3 million MRI–pathology pairs, is redefining prostate cancer diagnosis. The MRI‑PTPCa system delivers near‑perfect accuracy in grading tumors, offering a safe, noninvasive alternative to biopsies while improving clinical decision‑making and patient outcomes.

GLP-1 RAs May Halve Risk of Peptic Ulcer in Type 2 Diabetes

Learn how GLP-1 RAs may cut peptic ulcer risk in diabetes patients by nearly half.